HARNESSING SENESCENCE FOR HUMAN HEALTHSPAN

Atropos aims to treat aging-related diseases and cancer and improve healthspan with approved novel senescence- targeting drugs.

Atropos, the Fate whose duty it was

to cut the threads of life.

 

Robert S. Holzman, MD

The Legacy of Atropos, the Fate Who Cut the Thread of Life, 1998

NEWS

August 13, 2020

We are excited to collaborate with The Estée Lauder Companies

in a joint development agreement to discover senomodulators!  >>

©2018 by Atropos Therapeutics Inc.. Proudly created with Wix.com